Abstract
Objective and design
Antithrombin is known as the most important natural coagulation inhibitor and has been shown to have anti-inflammatory properties. The present study aimed to investigate the effects of Bothrops jararaca antithrombin on acute inflammation induced by carrageenan in mice.
Methods
We evaluated the anti-inflammatory activity of antithrombin on models of paw edema formation, cell migration and leukocyte–endothelium interaction in mice (Swiss; n = 5). Acute inflammation was induced by the administration of carrageenan (15 mg kg−1).
Results
Treatment with B. jararaca antithrombin (1 mg kg−1) 1 h before or after carrageenan administration significantly inhibited paw edema formation, reduced cell influx to the peritoneal cavity due to reduction in the migration of polymorphonuclear cells, and attenuated leukocyte rolling in the microcirculation of the cremaster muscle.The effects of antithrombin on vascular and cellular events of inflammation were completely abolished by treatment with the cyclo-oxygenase inhibitor indomethacin (4 mg kg−1), suggesting the involvement of prostacyclin in the mechanism of inflammation inhibition by B. jararaca antithrombin.
Conclusion
This work showed for the first time the anti-inflammatory properties of B. jararaca antithrombin on vascular and cellular events of inflammation. These findings suggest that antithrombin is effective in preventing paw edema formation, cell migration and leukocyte rolling induced by carrageenan in mice.
Similar content being viewed by others
References
Gettins PG. Serpin structure, mechanism, and function. Chem Rev. 2002;102(12):4751–804. doi:cr010170.
Bayston TA, Lane DA. Antithrombin: molecular basis of deficiency. Thromb Haemost. 1997;78(1):339–43.
Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis. 2002;13(8):657–70.
Wiedermann ChJ, Romisch J. The anti-inflammatory actions of antithrombin–a review. Acta Med Austriaca. 2002;29(3):89–92.
Kaneider NC, Egger P, Dunzendorfer S, Wiedermann CJ. Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun. 2001;287(1):42–6. doi:10.1006/bbrc.2001.5534.
Kaneider NC, Reinisch CM, Dunzendorfer S, Romisch J, Wiedermann CJ. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J Cell Sci. 2002;115(Pt 1):227–36.
Ostrovsky L, Woodman RC, Payne D, Teoh D, Kubes P. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation. 1997;96(7):2302–10.
Zuo XJ, Okada Y, Nicolaidou E, Toyoda T, Marchevsky A, Matloff JM, et al. Antithrombin III inhibits T and B lymphocyte activation in vitro and improves parameters of inflammation in a rat model of acute lung allograft rejection. Transplant Proc. 1999;31(1–2):847–8. doi:S0041-1345(98)01800-4.
Hoffmann JN, Vollmar B, Romisch J, Inthorn D, Schildberg FW, Menger MD. Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit Care Med. 2002;30(1):218–25.
Yamauchi T, Umeda F, Inoguchi T, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun. 1989;163(3):1404–11.
Okajima K, Uchiba M. The anti-inflammatory properties of antithrombin III: new therapeutic implications. Semin Thromb Hemost. 1998;24(1):27–32.
Dunzendorfer S, Kaneider N, Rabensteiner A, Meierhofer C, Reinisch C, Romisch J, et al. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood. 2001;97(4):1079–85.
Dickneite G, Leithauser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol. 1999;19(6):1566–72.
Dickneite G, Paques EP. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis. Thromb Haemost. 1993;69(2):98–102.
Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T, Noguchi T. High-dose antithrombin III prevents heat stroke by attenuating systemic inflammation in rats. Inflamm Res. 2010;59(7):511–8. doi:10.1007/s00011-009-0155-y.
Sun HM, Hong LZ, Shen XK, Lin XQ, Song Y, Shi Y. Antithrombin-III without concomitant heparin improves endotoxin-induced acute lung injury rats by inhibiting the activation of mitogen-activated protein kinase. Chin Med J (Engl). 2009;122(20):2466–71.
Inthorn D, Hoffmann JN, Hartl WH, Muhlbayer D, Jochum M. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock. 1998;10(2):90–6.
Iba T, Kidokoro A, Fukunaga M, Nagakari K, Suda M, Yoshikawa S, et al. Antithrombin ameliorates endotoxin-induced organ dysfunction more efficiently when combined with danaparoid sodium than with unfractionated heparin. Intensive Care Med. 2005;31(8):1101–8. doi:10.1007/s00134-005-2707-0.
Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. Caring for the critically ill patient: high-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001;286(15):1869–78. doi:jce10000.
Wiedermann CJ, Hoffmann JN, Juers M, Ostermann H, Kienast J, Briegel J, et al. High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Crit Care Med. 2006;34(2):285–92. doi:00003246-200602000-00001.
de Morais KB, Vieira CO, Hirata IY, Tanaka-Azevedo AM. Bothrops jararaca antithrombin: isolation, characterization and comparison with other animal antithrombins. Comp Biochem Physiol B: Biochem Mol Biol. 2009;152(2):171–6.
Morais-Zani K, Tanaka AS, Tanaka-Azevedo AM. Isolation of Bothrops jararaca snake antithrombin from the supernatant of fibrinogen purification. J Biomol Tech. 2009;20(5):249–52.
Stoscheck CM. Quantification of protein. Methods Enzymol. 1990;182:50–68.
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150(1):76–85.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(259):680–5.
Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996;68(5):850–8.
Levy L. Carrageenan paw edema in the mouse. Life Sci. 1969;8(11):601–6.
Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. In: Burcherl W, Buckley EE, Deulofeu V, editors. Venomous animals and their venoms. New York: Academic Press; 1971. p. 345–841.
Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res. 1973;5(3):384–94.
Lomonte B, Lundgren J, Johansson B, Bagge U. The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study. Toxicon. 1994;32(1):41–55.
Carrell RW. How serpins are shaping up. Science. 1999;285(5435):1861.
Bjork I, Jackson CM, Jornvall H, Lavine KK, Nordling K, Salsgiver WJ. The active site of antithrombin: release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin. J Biol Chem. 1982;257(5):2406–11.
Vieira CO, Tanaka AS, Sano-Martins IS, Morais KB, Santoro ML, Tanaka-Azevedo AM. Bothrops jararaca fibrinogen and its resistance to hydrolysis evoked by snake venoms. Comp Biochem Physiol B: Biochem Mol Biol. 2008;151(4):428–32.
Tanaka-Azevedo AM, Tanaka AS, Sano-Martins IS. A new blood coagulation inhibitor from the snake Bothrops jararaca plasma: isolation and characterization. Biochem Biophys Res Commun. 2003;308(4):706–12.
Tanaka-Azevedo AM, Torquato RJ, Tanaka AS, Sano-Martins IS. Characterization of Bothrops jararaca coagulation inhibitor (BjI) and presence of similar protein in plasma of other animals. Toxicon. 2004;44(3):289–94.
Morais KB, Grego KF, Tanaka-Azevedo AM. Identification of proteins similar to Bothrops jararaca coagulation inhibitor (BjI) in the plasmas of Bothrops alternatus, Bothrops jararacussu and Crotalus durissus terrificus snakes. Comp Biochem Physiol B: Biochem Mol Biol. 2008;149(2):236–40. doi:10.1016/j.cbpb.2007.09.011.
Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol. 2003;225:115–21. doi:10.1385/1-59259-374-7:115.
Sitonio MM, de Carvalho Junior CH, Campos ID, Silva JB, de Lima MD, Goes AJ, et al. Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (beta-lapachone). Inflamm Res. 2013;62:107–13. doi:10.1007/s00011-012-0557-0.
Henriques MG, Silva PM, Martins MA, Flores CA, Cunha FQ, Assreuy-Filho J et al. Mouse paw edema: a new model for inflammation? Brazilian J Med Biol Res 1987;20(2):243–9.
Chatterjee N, Das S, Bose D, Banerjee S, Chattopadhyay D, Saha KD. Exploring the anti-inflammatory activity of a novel 2-phenylquinazoline analog with protection against inflammatory injury. Toxicol Appl Pharmacol. 2012;264:181–94. doi:10.1016/j.taap.2012.07.032.
Meneguzzo DT, Lopes LA, Pallota R, Soares-Ferreira L, Lopes-Martins RA, Ribeiro MS. Prevention and treatment of mice paw edema by near-infrared low-level laser therapy on lymph nodes. Lasers Med Sci. 2012;. doi:10.1007/s10103-012-1163-7.
Rodrigues JA, Vanderlei ES, Silva LM, Araujo IW, Queiroz IN, Paula GA, et al. Antinociceptive and anti-inflammatory activities of a sulfated polysaccharide isolated from the green seaweed Caulerpa cupressoides. Pharm Reports: PR. 2012;64(2):282–92.
Godin AM, Ferreira WC, Rocha LT, Ferreira RG, Paiva AL, Merlo LA, et al. Nicotinic acid induces antinociceptive and anti-inflammatory effects in different experimental models. Pharmacol Biochem Behav. 2012;101(3):493–8. doi:10.1016/j.pbb.2012.02.012.
Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L, et al. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol. 2004;142(2):331–8. doi:10.1038/sj.bjp.0705650.
Harada N, Okajima K, Kushimoto S, Isobe H, Tanaka K. Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood. 1999;93(1):157–64.
Malech HL, Gallin JI. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med. 1987;317(11):687–94. doi:10.1056/NEJM198709103171107.
Saleh TS, Calixto JB, Medeiros YS. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides. 1999;20(8):949–56.
Utsunomiya I, Nagai S, Oh-ishi S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J Immunol. 1991;147(6):1803–9.
Cuzzocrea S, Sautebin L, De Sarro G, Costantino G, Rombola L, Mazzon E, et al. Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol. 1999;163(9):5094–104.
Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med. 2001;29(1):134–9.
Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65(5):859–73.
Yamashiro K, Kiryu J, Tsujikawa A, Honjo M, Nonaka A, Miyamoto K, et al. Inhibitory effects of antithrombin III against leukocyte rolling and infiltration during endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2001;42(7):1553–60.
Gritti D, Malinverno A, Gasparetto C, Wiedermann CJ, Ricevuti R. Attenuation of leukocyte beta 2-integrin expression by antithrombin-III. Int J Immunopathol Pharmacol. 2004;17(1):27–32.
Horie S, Ishii H, Kazama M. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res. 1990;59(6):895–904.
Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Physiol Cell Physiol. 2000;279(1):C98–107.
Acknowledgments
We acknowledge the Mass Spectrometry Laboratory at Brazilian Biosciences National Laboratory, CNPEM-ABTLuS, Campinas, Brazil for their support with the mass spectrometry analysis. This work was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (09/50199-2, 09/03484-3, 11/21558-4) and Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: Mauro Teixeira.
Rights and permissions
About this article
Cite this article
de Morais-Zani, K., Nunes, F.P.B., da Silva, J.B. et al. The anti-inflammatory action of Bothrops jararaca snake antithrombin on acute inflammation induced by carrageenan in mice. Inflamm. Res. 62, 733–742 (2013). https://doi.org/10.1007/s00011-013-0628-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-013-0628-x